In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs
Anna Fagotti, MD, PhD
Advertisement
Articles by Anna Fagotti, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer
2
Selecting Among Preferred 1L Regimens — A Discussion
3
What is the Future of TIL Therapy in Metastatic Melanoma?
4
Clinical Context & MARIPOSA Efficacy in 1L EGFRm NSCLC
5